CCT3 Facilitates the Malignant Progression of NSCLC and SCLC via PI3 K/AKT-EMT Axis and Emerges as a Novel Serum Diagnostic Biomarker

Introduction Identifying therapeutic targets and early screening biomarkers is essential for improving the prognosis of lung cancer. CCT3 has been linked to tumor progression; however, its role in lung cancer proliferation and invasion, as well as its diagnostic significance remain poorly understood...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Guobin Song PhD, Kexin Han MS, Lin Xiang PhD, Tian Peng PhD, Hailong Chen MS, Anqi Tang MS, Yanan Li PhD, Tianqi Lan MS, Houqun Ying PhD, Xuexin Cheng MS
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2026-01-01
Edice:	Technology in Cancer Research & Treatment
On-line přístup:	https://doi.org/10.1177/15330338251412203
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!